Cargando…

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective

Neuraminidase inhibitors (NAIs) are vital in managing seasonal and pandemic influenza infections. NAI susceptibilities of virus isolates (n = 5540) collected during the 2008–2009 influenza season were assessed in the chemiluminescent neuraminidase inhibition (NI) assay. Box-and-whisker plot analyses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okomo-Adhiambo, Margaret, Sleeman, Katrina, Ballenger, Kristina, Nguyen, Ha T., Mishin, Vasiliy P., Sheu, Tiffany G., Smagala, James, Li, Yan, Klimov, Alexander I., Gubareva, Larisa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185571/ https://www.ncbi.nlm.nih.gov/pubmed/21994620 http://dx.doi.org/10.3390/v2102269

Ejemplares similares

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2014)

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
por: Sleeman, Katrina, et al.
Publicado: (2011)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
por: Nguyen, Ha T., et al.
Publicado: (2013)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
por: Sleeman, Katrina, et al.
Publicado: (2013)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
por: Graitcer, Samuel B., et al.
Publicado: (2011)

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir
por: Patel, Mira C., et al.
Publicado: (2021)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
por: Gubareva, Larisa V, et al.
Publicado: (2017)

Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011
por: Lindstrom, Stephen, et al.
Publicado: (2012)

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006–2008
por: Deyde, Varough, et al.
Publicado: (2009)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
por: Govorkova, Elena A., et al.
Publicado: (2022)

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test
por: Hodges, Erin N., et al.
Publicado: (2019)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
por: Storms, Aaron D., et al.
Publicado: (2012)

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
por: Nguyen, Ha T., et al.
Publicado: (2023)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods
por: Patel, Mira C., et al.
Publicado: (2020)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010–2015
por: Tewawong, Nipaporn, et al.
Publicado: (2018)

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
por: Jorquera, Patricia A., et al.
Publicado: (2019)

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors
por: Tolah, Ahmed M., et al.
Publicado: (2016)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
por: Marjuki, Henju, et al.
Publicado: (2016)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_500obgqa3enkctmjuv287ncqlv